Jump to content

Effect Of GLP-1 Based Therapies On Diabetic Dyslipidemia: Revision history

Diff selection: Mark the radio buttons of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

7 September 2026

  • curprev 10:5810:58, 7 September 2026 TerranceMarvin talk contribs 5,654 bytes +5,654 Created page with "<br>Glucagon-like peptide-1 (GLP-1), is a hormone secreted by small intestine. Consumption of food or glucose stimulates synthesis and secretion of GLP-1 in the bloodstream, which in turn stimulates insulin secretion from pancreas and delays gastric emptying. Owing to the favorable spectrum of effects on reduction of hyperglycemia and body weight, [http://scubarama.ca/index.php/Modulation_Of_Taste_Sensitivity MedicGLP Capsules] GLP-1 mimetics are intensely pursued as th..."
Retrieved from "https://www.mipiwiki.com/index.php/Effect_Of_GLP-1_Based_Therapies_On_Diabetic_Dyslipidemia"